Alantra advises the shareholders of Aakamp on the sale to Procemsa
Madrid/Frankfurt am Main — Alantra, the global investment banking and asset management firm focused on the mid-market segment, has advised the shareholders of Aakamp GmbH (“Aakamp”), a leading German manufacturer of vitamins, minerals and nutritional supplements (VMS), on the sale of the company to Farmaceutici Procemsa (“Procemsa”). Procemsa, a company held by Investindustrial Growth L.P. (“Investindustrial”), specializes in the production, packaging, and research and development of nutritional supplements. The closing of the transaction was announced today.
Founded in 2009, Aakamp is the main contract manufacturer for German VMS brands in the direct-to-consumer (D2C) segment. Since 2019, Auctus Capital Partners, a leading German buy and build investor, has been a majority shareholder in the company alongside founder Alexander Keibel and the management team. Aakamp offers the full range of dietary supplements (including capsules, tablets, softgels, liquids and powders) and a full range of services (including product development, production, packaging, labeling and storage). Aakamp has a state-of-the-art and ‑flexible production facility in Breddorf and employs around 200 people. Under the leadership of founder Alexander Keibel, who will continue to serve as CEO, Aakamp has achieved exceptional and steady growth over the past decade.
With the acquisition of Aakamp by Procemsa, Investindustrial continues its strategy to build a European leader in the VMS sector. The transaction provides access to the German market, which at €2.5 billion is the third largest in Europe after Italy and the United Kingdom. It is characterized by the fastest growing D2C segment and is therefore of particular strategic importance. Procemsa is one of the largest players in the European VMS market following the completion of the transaction.
The transaction underscores Alantra’s leading position as an international midmarket M&A advisor to the VMS and nutritional supplements sectors. Alantra recently advised on the divestments of Bee Health (UK) to INW, Nutriscience Innovations (USA) to Tilia Capital, GS Capsule (China) to Advent International, Patent Co (Serbia) to RWA, and the acquisition of UAS Laboratories (USA) by Chr. Hansen and OFI (Italy) by Procemsa.
Charles Lanceley, Head of UK Food & Nutrition, and Christopher Jobst, Partner at Alantra Germany, led the transaction with the support of a team from the UK and Germany. The team’s extensive industry knowledge and close relationships with strategists enabled them to achieve a highly successful outcome for Aakamp.
Christopher Jobst said: “As a leading provider on the German VMS market and an indispensable partner for its customers, Aakamp was a sought-after asset on the European market. Together with founder Alexander Keibel and the other shareholders, we examined numerous options that would meet both the shareholders’ and the company’s requirements in the long term. We are pleased to have found a partner in Procemsa that is an ideal strategic and cultural fit for Aakamp, and we look forward to the company’s continued success.”
Charles Lanceley added, “Consumer spending on dietary supplements in Europe is at record levels, and improving health and well-being is among the major trends. Leading companies like Aakamp play a critical role in the VMS supply chain as innovators, developers and manufacturers, and will therefore continue to attract strong interest from strategic buyers and financial investors.”
Alexander Keibel, CEO of Aakamp, said: “We are very proud to have gained the trust of a partner like Investindustrial and to be able to work with a large group like Procemsa in the future. Our market is rapidly evolving due to digitalization and we are convinced that our international footprint will strengthen Procemsa’s positioning in the sector. We would like to thank Alantra for their support in this process. The cross-border collaboration has worked seamlessly and brought great added value.”
Andrea Bonomi, Chairman of Investindustrial’s Industrial Advisory Board, said, “This acquisition is another example of the successful consolidation strategy that Investindustrial has implemented since the beginning of its operations, making and successfully integrating more than 150 add-on acquisitions for its portfolio companies. Procemsa is in an excellent position to successfully continue its international expansion through both acquisitions and organic growth. With Aakamp, we have found a valuable addition to strengthen our position in the important German market.”
Alantra is a global alternative asset management, investment banking and credit portfolio advisory firm focused on providing services to businesses, families and investors operating in the middle market segment. The Group has more than 540 professionals in Europe, the USA, Latin America and Asia. The Investment Banking division provides independent advice on M&A, debt advisory, restructuring and capital markets transactions and has advised on more than 450 transactions with a total value of over €70 billion in the last three years. Alantra’s specialists have both extensive global sector expertise and strong relationships with local companies, investors, entrepreneurs and financing institutions in each of their markets. www.alantra.com